Contraindications of Digoxin
Absolute Contraindications :
❶ Ventricular fibrillation
❷ Digoxin hypersensitivity
Relative Contraindications :
① Acute MI
② Myocarditis
③ HOCM
④ Sick sinus syndrome
⑤ AV block (2nd- or 3rd-degree) without a pacemaker
⑥ WPW syndrome with AF
Drug Interactions that Can Function as Contraindications :
☒ Amiodarone
☒ Dronedarone
☒ Verapamil
☒ Macrolides (e.g., clarithromycin)
☒ Itraconazole
Conditions that Increase Risk of Digoxin Toxicity :
➠ Renal impairment
➠ Hyperthyroidism or Hypothyroidism
➠ Elderly or low body mass
➠ Electrolyte disturbances :
➜ Hypokalemia
➜ Hypomagnesemia
➜ Hypercalcemia
For more infographics keep visiting: drmusmanjaved.com
Contraindications of Digoxin – A Detailed Clinical Guide
Digoxin is one of the oldest and most widely used cardiac medications, particularly in patients with atrial fibrillation and heart failure with reduced ejection fraction (HFrEF) whose primary problem is symptomatic congestion despite optimal therapy.
Although effective, digoxin has a narrow therapeutic index, meaning the margin between therapeutic and toxic levels is small. Therefore, understanding its contraindications, drug interactions, and toxicity-predisposing conditions is crucial for safe use.
This article reviews all contraindications—absolute, relative, and interaction-based—along with clinical reasoning behind each.
---
π΄ Absolute Contraindications
These are conditions in which digoxin must not be used under any circumstance.
1. Ventricular Fibrillation
Digoxin is completely ineffective in controlling ventricular fibrillation and may worsen arrhythmogenicity due to increased intracellular calcium.
It should never be given in a patient with ongoing VF.
2. Digoxin Hypersensitivity
Any history of allergic reaction—urticaria, angioedema, rash, or anaphylaxis—makes further exposure unsafe.
---
π Relative Contraindications
These are situations where digoxin may be used but require caution and often specialist input.
1. Acute Myocardial Infarction (AMI)
Digoxin increases myocardial oxygen consumption and can worsen ischemia or provoke arrhythmias during an acute infarction.
2. Myocarditis
Inflamed myocardium is more irritable, and digoxin can heighten arrhythmia risk due to increased automaticity.
3. Hypertrophic Obstructive Cardiomyopathy (HOCM)
Digoxin increases contractility.
In HOCM, this can worsen LVOT obstruction and exacerbate symptoms.
4. Sick Sinus Syndrome
Digoxin increases vagal tone and may worsen underlying bradyarrhythmias unless a pacemaker is present.
5. 2nd- or 3rd-Degree AV Block (Without Pacemaker)
Because digoxin slows AV nodal conduction, it can precipitate complete heart block in patients with pre-existing conduction disease.
6. WPW Syndrome with Atrial Fibrillation
This is a classic danger:
Digoxin enhances conduction through accessory pathways, leading to very rapid ventricular rates or degeneration into VF.
---
π΄ Drug Interactions That Act as Contraindications
Certain medications dramatically increase serum digoxin levels or enhance toxicity. Their presence often makes digoxin unsafe unless dose adjustment and close monitoring occur.
1. Amiodarone
Inhibits P-glycoprotein, causing digoxin levels to double.
Co-administration requires a 50% dose reduction and serum level monitoring.
2. Dronedarone
Similar interaction to amiodarone—strong P-gp inhibition and increased risk of bradyarrhythmias.
3. Verapamil
Raises digoxin concentrations and adds a compounding negative chronotropic effect.
4. Macrolides (e.g., clarithromycin)
Suppress gut flora responsible for digoxin metabolism, causing dangerous toxicity surges.
5. Itraconazole
Potent P-gp inhibitor → markedly elevated digoxin levels.
Clinical pearl:
Any new P-glycoprotein inhibitor in a patient on digoxin requires immediate reassessment of therapy.
---
π‘ Conditions That Increase the Risk of Digoxin Toxicity
These are not absolute contraindications, but they increase susceptibility dramatically.
1. Renal Impairment
Digoxin is primarily renally cleared. Even mild renal dysfunction can raise serum levels and lead to toxicity (nausea, vision changes, arrhythmias).
2. Thyroid Disease
Hyperthyroidism: Increased metabolism → fluctuating digoxin effects and arrhythmia risk.
Hypothyroidism: Reduced clearance → higher digoxin levels.
3. Elderly Age or Low Body Mass
Reduced volume of distribution and decreased renal clearance make older adults highly prone to toxicity.
4. Electrolyte Abnormalities
These are the most dangerous enhancers of toxicity:
Hypokalemia: Low K⁺ increases digoxin binding to the Na⁺/K⁺ pump → potentiates toxicity.
Hypomagnesemia: Promotes ventricular arrhythmias.
Hypercalcemia: Amplifies calcium-overload effects → triggered arrhythmias.
Remember:
“Low K, Low Mg, High Ca = Perfect Storm for Digoxin Toxicity.”
---
Clinical Practice Takeaways
Always check renal function and electrolytes before prescribing.
Avoid digoxin in patients with WPW-AF, advanced AV block, or myocarditis.
Review all medications for P-gp interactions.
In elderly patients, start with very low doses and monitor levels.
Digoxin toxicity can be life-threatening—recognize early symptoms (GI upset, yellow vision, bradyarrhythmias, VT/VF risk).
---
Conclusion
Digoxin remains a valuable medication when used correctly. However, its narrow therapeutic window requires careful assessment of contraindications and interacting factors. Understanding these risk modifiers helps clinicians use digoxin safely and effectively, avoiding preventable complications.

Comments
Post a Comment
Drop your thoughts here, we would love to hear from you